Blood Brain Barrier Technologies Market Scope And Analysis

  • Report Code : TIPRE00021883
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 157
Buy Now

Blood Brain Barrier Technologies Market Size and Scope 2031

Buy Now

Blood Brain Barrier Technologies Market Report Blood Brain Barrier Technologies Market Size and Share Blood Brain Barrier Technologies Market Scope and Analysis

Blood Brain Barrier Technologies Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.04 Billion
Market Size by 2028 US$ 5.1 Billion
Global CAGR (2021 - 2028) 25.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • Bispecific Antibody RMT Approach
  • Trojan Horse Approach
  • Increasing Permeability
  • Passive Diffusion
  • Other Non-Invasive BBB Technologies
By Application
  • Alzheimer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • Pfizer Inc
  • Johnson and Johnson Services Inc
  • Fabre Kramer Pharmaceuticals Inc
  • Bioasis Technologies Inc
  • Abliva AB

    •  

    Company Profiles

    • Teva Pharmaceutical Industries Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Eli Lilly and Company.
    • Bristol-Myers Squibb Company
    • Pfizer, Inc.
    • Johnson and Johnson Services, Inc.
    • Fabre-Kramer Pharmaceuticals, Inc.
    • Bioasis Technologies Inc.
    • Abliva AB
    • JCR Pharmaceuticals Co., Ltd.